Projects funded by the NCN
Understanding of the mesenchymal stem cells (MSCs)-mediated immune suppression mechanism in the neutrophilic experimental asthma model as a way to identify novel potential therapeutic targets
2020/37/N/NZ5/04144
Keywords:
asthma mesenchymal stem cells lipid mediators
Descriptors:
- NZ5_007:
- NZ6_001:
- NZ3_008:
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny w Białymstoku, Wydział Lekarski z Oddziałem Stomatologii i Oddziałem Nauczania w Języku Angielskim
woj. podlaskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 19 - announced on 2020-03-16
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2021-06-01
Project end date (Y-m-d): 2025-05-31
Project duration:: 48 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- The short-term and long-term effects of intranasal mesenchymal stem cell administration to noninflamed mice lungAuthors:Marlena Tynecka, Adrian Janucik, Magdalena Niemira, Arkadiusz Zbikowski, Nino Stocker, Agnieszka Tarasik, Aleksandra Starosz, Kamil Grubczak, Anna Szalkowska, Urszula Korotko, Joanna Reszec, Miroslaw Kwasniewski, Adam Kretowski, Cezmi Akdis, Milena Sokolowska, Marcin Moniuszko, Andrzej EljaszewiczAcademic press:Frontiers in Immunology (rok: 2022, tom: Volume 13, strony: 45669), Wydawca: FrontiersStatus:PublishedDOI:10.3389/fimmu.2022.967487 - link to the publication